Sign up to save your podcasts
Or
Share Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes
Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip.
Send us a text
View all episodes
By Andrew Hattersley and Maggie Shepherd
5
66 ratings
Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip.
Send us a text
More shows like One in Six Billion
View all
This American Life
91,052 Listeners
More or Less
884 Listeners
Diabetes Core Update
102 Listeners
The Intelligence from The Economist
2,546 Listeners
Cautionary Tales with Tim Harford
5,174 Listeners
The Rest Is Politics
3,110 Listeners
ZOE Science & Nutrition
2,078 Listeners
Diabetes Care "On Air"
12 Listeners
The Glucose Never Lies® Podcast
4 Listeners